15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering CareDx Inc, 1 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets range widely, $21.00 to $45.00 (about 2.1x), a sign of real disagreement on valuation. The average target of $33.00 sits 8% below the current $35.75. The rating mix has stayed broadly stable, with Buy-side ratings easing from 3 to 1 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.19 next quarter toward $1.13 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to CareDx Inc.
As of Jul, 1 of 3 firms rate CDNA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CDNA EPS & revenue forecast
EPS · NEXT QUARTER
$0.19
Range $0.17 – $0.21 · 5 analysts · -33% YoY
Next period, 5 analysts expect CareDx Inc to earn $0.19 a share (range $0.17 – $0.21), versus $0.28 a year earlier. Full-year consensus is $0.93, growing to $1.13 the year after.
REVENUE · NEXT QUARTER
$111.5M
Range $110.5M – $112.1M · 5 analysts · +11% YoY
Revenue is expected to reach $111.5M (range $110.5M – $112.1M), +11.4% year-over-year. Full-year consensus is $455.9M, rising to $481.3M next year.
Top analysts covering CareDx Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CDNA.
#1
Matthew Sykes
Goldman Sachs · Rank #226
Buy
$26.00-27.3% to target
Overall win rate
37%
+ Follow
#2
Yi Chen
HC Wainwright & Co. · Rank #238
Hold
$25.00-30.1% to target
Overall win rate
34%
+ Follow
#3
Mark Massaro
BTIG
Buy
$45.00+25.9% to target
Coverage
—
+ Follow
#4
Brandon Couillard
Wells Fargo
Hold
$21.00-41.3% to target
Coverage
—
+ Follow
#5
CC
Connor Chamberlain
Craig-Hallum
Buy
$26.00-27.3% to target
Coverage
—
+ Follow
CDNA stock forecast FAQ
What is CDNA's average 12-month price target?+
The 2 analysts with a live target average $33.00 for CareDx Inc over the next 12 months, ranging from a $45.00 high to a $21.00 low.
Is CDNA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 1 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CDNA?+
The Street-high target is $45.00 (BTIG), and the Street-low is $21.00 (Wells Fargo). The average of all 2 active targets is $33.00.
How many Wall Street analysts cover CDNA?+
3 analysts have an active rating on CareDx Inc, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering CDNA?+
Among analysts who currently cover CDNA, Matthew Sykes of Goldman Sachs has the strongest overall Quantellect track record (Rank #226). Their current call is Buy with a $26.00 target.
What is CareDx Inc's projected EPS for next quarter?+
The consensus estimate is $0.19 per share (range $0.17 – $0.21) across 5 analysts. Full-year EPS is projected at $0.93, rising to $1.13 the following year.
How much revenue is CareDx Inc expected to report next quarter?+
Consensus revenue is $111.5M (range $110.5M – $112.1M). Full-year revenue is projected at $455.9M, growing to $481.3M next year.
Have analysts been upgrading or downgrading CDNA lately?+
As of Jul, 1 of 3 firms rate CDNA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CDNA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
